Literature DB >> 15180780

Development of neuropsychiatric symptoms in poststroke patients: a cross-sectional study.

P Angelelli1, S Paolucci, U Bivona, L Piccardi, P Ciurli, A Cantagallo, G Antonucci, L Fasotti, A Di Santantonio, M G Grasso, L Pizzamiglio.   

Abstract

OBJECTIVE: The study aimed to characterize neuropsychiatric symptomatology and its evolution in a large group of poststroke patients during their first year.
METHOD: The Neuropsychiatric Inventory (NPI) was administered to a sample of 124 poststroke patients, divided into three independent groups on the basis of time from stroke (2, 6 and 12 months). The controls were 61 healthy subjects.
RESULTS: A wide range of neuropsychiatric symptoms was found significant in the poststroke population: mostly depression (61%), irritability (33%), eating disturbances (33%), agitation (28%), apathy (27%) and anxiety (23%). Modifications in terms of greater depression, anxiety, irritability and eating disturbances evolved in the year following stroke. Other symptoms were significantly present depending on time from stroke. Clear relations with other clinical and demographic variables were also found.
CONCLUSION: Neuropsychiatric symptoms constitute an important part of comorbidity in stroke patients; thus, suitable assessment tools may improve clinical understanding of these patients. Copyright Blackwell Munksgaard 2004.

Entities:  

Mesh:

Year:  2004        PMID: 15180780     DOI: 10.1111/j.1600-0447.2004.00297.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  30 in total

1.  The impact of anger in adherence to treatment and beliefs about disease 1 year after stroke.

Authors:  A Catarina Santos; José M Ferro
Journal:  J Neurol       Date:  2017-08-02       Impact factor: 4.849

2.  Correlations between Pre-morbid Personality and Depression Scales in Stroke Patients.

Authors:  Sung Il Hwang; Kyung In Choi; Oak Tae Park; Si-Woon Park; Eun Seok Choi; Sook-Hee Yi
Journal:  Ann Rehabil Med       Date:  2011-06-30

Review 3.  Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment.

Authors:  Thomas N Chase
Journal:  Neurotox Res       Date:  2010-05-15       Impact factor: 3.911

4.  A one-year follow-up study into the course of depression after stroke.

Authors:  A Bour; S Rasquin; I Aben; A Boreas; M Limburg; F Verhey
Journal:  J Nutr Health Aging       Date:  2010-06       Impact factor: 4.075

5.  Temporal relationships between depressive symptoms and white matter hyperintensities in older men and women.

Authors:  Vonetta M Dotson; Alan B Zonderman; Michael A Kraut; Susan M Resnick
Journal:  Int J Geriatr Psychiatry       Date:  2012-03-13       Impact factor: 3.485

6.  Predictivity of Early Depressive Symptoms for Post-Stroke Depression.

Authors:  A Lewin-Richter; M Volz; M Jöbges; K Werheid
Journal:  J Nutr Health Aging       Date:  2015-08       Impact factor: 4.075

7.  Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.

Authors:  Katherine A Treiber; Constantine G Lyketsos; Chris Corcoran; Martin Steinberg; Maria Norton; Robert C Green; Peter Rabins; David M Stein; Kathleen A Welsh-Bohmer; John C S Breitner; JoAnn T Tschanz
Journal:  Int Psychogeriatr       Date:  2008-02-21       Impact factor: 3.878

8.  Geriatric rehabilitation of stroke patients in nursing homes: a study protocol.

Authors:  Monica Spruit-van Eijk; Bianca I Buijck; Sytse U Zuidema; Frans L M Voncken; Alexander C H Geurts; Raymond T C M Koopmans
Journal:  BMC Geriatr       Date:  2010-03-27       Impact factor: 3.921

9.  Ecological Momentary Assessment of Social Interactions: Associations With Depression, Anxiety, Pain, and Fatigue in Individuals With Mild Stroke.

Authors:  Anna J Neff; Yejin Lee; Christopher L Metts; Alex W K Wong
Journal:  Arch Phys Med Rehabil       Date:  2020-09-09       Impact factor: 3.966

Review 10.  Neuropsychiatric sequelae of stroke.

Authors:  José M Ferro; Lara Caeiro; Maria Luísa Figueira
Journal:  Nat Rev Neurol       Date:  2016-04-11       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.